MENU
INCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Incyte (INCY) Ownership - Who owns Incyte?
Incyte focuses on the discovery and development of small-molecule drugs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.31B
P/E Ratio
18.53
Total Cash
2.42B
Projected Growth
0.14
Total Debt
42.41M
Revenue
4.58B
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash/Share
12.40
Total Debt/Equity
N/A
Revenue/Share
23.03 USD as % of share price
Fundamentals
INCY
Capitalization
15.3B
P/E Ratio
18.53
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash
2.42B
Total Cash/Share
12.40
Total Debt
42.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.14
Revenue/Share (as % of the share price)
23.03%
Revenue
4.59B
ROE
N/A
Book Value
4.17B
P/B Ratio
3.67
Cash Flow
N/A
Earnings
4.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
194K
Current Ratio
2.85
Current Revenue Per Employee
464474.22
Dividends Per Share - Security
N/A
EBITDA
1.36B
Float
N/A
Float - Current
N/A
Gross Income Margin
93.52
Revenue To Assets
16.61
Shares Held By Institutions
28.4B
Shares Outstanding - Current
195M
Total Liabilities
1.65B
Total Volume MTD
N/A
Value
N/A
Gain YTD
13.494
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INCY showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com